A novel rabbit derived anti-HER2 antibody with pronounced therapeutic effectiveness on HER2-positive breast cancer cells in vitro and in humanized tumor mice (HTM)

BACKGROUND: Antibody based cancer therapies have achieved convincing success rates combining enhanced tumor specificity and reduced side effects in patients. Trastuzumab that targets the human epidermal growth factor related receptor 2 (HER2) is one of the greatest success stories in this field. For...

Descripción completa

Detalles Bibliográficos
Autores principales: Wege, Anja Kathrin, Kirchhammer, Nicole, Kazandjian, Linda Veronique, Prassl, Sandra, Brandt, Michael, Piendl, Gerhard, Ortmann, Olaf, Fischer, Stephan, Brockhoff, Gero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429704/
https://www.ncbi.nlm.nih.gov/pubmed/32799890
http://dx.doi.org/10.1186/s12967-020-02484-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429704/
https://www.ncbi.nlm.nih.gov/pubmed/32799890
http://dx.doi.org/10.1186/s12967-020-02484-9

Ejemplares similares